Your browser doesn't support javascript.
loading
Enantio- and Diastereoselective Total Synthesis of Belzutifan Enabled by Rh-Catalyzed Hydrogenation.
Le, Diane N; Johnson, Heather C; Lam, Yu-Hong; Sun, Chunrui; Cheng, Lili; Belyk, Kevin M.
Afiliación
  • Le DN; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Johnson HC; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Lam YH; Modeling and Informatics, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Sun C; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Cheng L; Chemistry Service Unit, WuXi AppTec (Tianjin), Tianjin 300457, China.
  • Belyk KM; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
Org Lett ; 26(19): 4059-4064, 2024 May 17.
Article en En | MEDLINE | ID: mdl-38709100
ABSTRACT
Herein, we report a nine-step synthesis of belzutifan enabled by a novel Rh-catalyzed asymmetric hydrogenation to install the contiguous fluorinated stereocenters with high enantioselectivity. Moreover, the final ketone reduction in the synthesis proceeds with high diastereoselectivity, leading to the expedient assembly of the stereotriad. In contrast to the original 16-step synthesis, this route avoids a lengthy bromination-oxidation sequence and introduces the sulfone functionality via nucleophilic aromatic substitution, obviating the need for transition metal catalysis.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Org Lett Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Org Lett Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos